Free tool
FAERS Monitor: Miralax
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020698 or its brand name (Miralax, Polyethylene Glycol 3350). Reports on generic versions are filed under their own applications.
Reports
91,485
Serious
35,712
39% of reports
Hospitalization
19,863
Death reported
5,768
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- product use issue9,984
- drug ineffective9,750
- off label use9,082
- diarrhoea6,906
- nausea5,179
- constipation5,028
- fatigue4,494
- product use in unapproved indication3,743
- vomiting3,140
- incorrect drug administration duration2,828
- incorrect dose administered2,808
- pain2,794
- death2,687
- headache2,657
- dyspnoea2,590
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 203 |
| 2005 | 247 |
| 2006 | 305 |
| 2007 | 327 |
| 2008 | 496 |
| 2009 | 625 |
| 2010 | 757 |
| 2011 | 957 |
| 2012 | 2,208 |
| 2013 | 4,116 |
| 2014 | 4,034 |
| 2015 | 6,832 |
| 2016 | 8,844 |
| 2017 | 8,277 |
| 2018 | 7,659 |
| 2019 | 6,756 |
| 2020 | 6,680 |
| 2021 | 6,010 |
| 2022 | 5,617 |
| 2023 | 5,158 |
| 2024 | 5,054 |
| 2025 | 6,064 |
| 2026 | 4,258 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,962,674 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| incorrect drug administration durationSignal | 2,828 | 25.6 | 24.6 | 60,155 |
| product use issueSignal | 9,984 | 12.8 | 12.6 | 104,157 |
| constipationSignal | 5,028 | 5.4 | 5.3 | 17,800 |
| product use in unapproved indicationSignal | 3,743 | 3.5 | 3.4 | 6,693 |
| incorrect dose administeredSignal | 2,808 | 2.9 | 2.7 | 3,368 |
| diarrhoeaSignal | 6,906 | 2.5 | 2.4 | 6,197 |
| off label useSignal | 9,082 | 2.4 | 2.4 | 7,650 |
| drug ineffective | 9,750 | 1.7 | 1.7 | 3,016 |
| vomiting | 3,140 | 1.5 | 1.5 | 602 |
| nausea | 5,179 | 1.5 | 1.5 | 914 |
| fatigue | 4,494 | 1.3 | 1.3 | 377 |
| dyspnoea | 2,590 | 1.1 | 1.0 | 7 |
| pain | 2,794 | 1.0 | 1.0 | 6 |
| headache | 2,657 | 1.0 | 0.9 | 2 |
| death | 2,687 | 0.7 | 0.7 | 314 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.